Advances in the development of biomarkers for epilepsy

The Lancet Neurology - Tập 15 - Trang 843-856 - 2016
Asla Pitkänen1, Wolfgang Löscher2,3, Annamaria Vezzani4, Albert J Becker5, Michele Simonato6,7, Katarzyna Lukasiuk8, Olli Gröhn1, Jens P Bankstahl9, Alon Friedman10,11, Eleonora Aronica12,13,14, Jan A Gorter13, Teresa Ravizza4, Sanjay M Sisodiya15,16, Merab Kokaia17, Heinz Beck18,19
1Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
2Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine Hannover, Germany
3Center for Systems Neuroscience, Hannover, Germany
4Department of Neuroscience, Experimental Neurology, IRCCS-Istituto di Recerche Farmacologiche “Mario Negri”, Milan, Italy
5Section for Translational Epilepsy Research, Department of Neuropathology, University of Bonn Medical Center, University of Bonn, Bonn, Germany
6Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy
7Unit of Gene Therapy of Neurodegenerative Diseases, Division of Neuroscience, University Vita-Salute San Raffaele, Milan, Italy
8The Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
9Preclinical Molecular Imaging, Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
10Department of Brain and Cognitive Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Israel
11Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada
12Department of Neuropathology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
13Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, Netherlands
14Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands
15Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK
16Epilepsy Society, Chalfont St. Peter, Buckinghamshire, UK
17Epilepsy Center, Experimental Epilepsy Group, Division of Neurology, Department of Clinical Sciences, Lund University Hospital, Lund, Sweden
18Laboratory for Experimental Epileptology and Cognition Research, Department of Epileptology, University of Bonn, Bonn, Germany
19German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Tài liệu tham khảo

Perucca, 2007, Development of new antiepileptic drugs: challenges, incentives, and recent advances, Lancet Neurol, 6, 793, 10.1016/S1474-4422(07)70215-6 Pitkänen, 2014, Epilepsy related to traumatic brain injury, Neurotherapeutics, 11, 286, 10.1007/s13311-014-0260-7 Pitkänen, 2014, Past and present definitions of epileptogenesis and its biomarkers, Neurotherapeutics, 11, 231, 10.1007/s13311-014-0257-2 Nieh, 2014, Epileptic encephalopathies: new genes and new pathways, Neurotherapeutics, 11, 796, 10.1007/s13311-014-0301-2 Schmidt, 2012, Evidence-based review on the natural history of the epilepsies, Curr Opin Neurol, 25, 159, 10.1097/WCO.0b013e3283507e73 Gaitatzis, 2004, The psychiatric comorbidity of epilepsy, Acta Neurol Scand, 110, 207, 10.1111/j.1600-0404.2004.00324.x Gaitatzis, 2004, The epidemiology of the comorbidity of epilepsy in the general population, Epilepsia, 45, 1613, 10.1111/j.0013-9580.2004.17504.x Kandratavicius, 2012, Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits, Rev Bras Psiquiatr, 34, 454, 10.1016/j.rbp.2012.04.007 Simonato, 2014, The challenge and promise of anti-epileptic therapy development in animal models, Lancet Neurol, 13, 949, 10.1016/S1474-4422(14)70076-6 Wang, 2015, Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy, Sci Rep, 5, 9522, 10.1038/srep09522 Wang, 2015, Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy, Sci Rep, 5, 10201, 10.1038/srep10201 Choy, 2014, A novel, noninvasive, predictive epilepsy biomarker with clinical potential, J Neurosci, 34, 8672, 10.1523/JNEUROSCI.4806-13.2014 Pollard, 2012, The TARC/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy, Front Neurol, 3, 181 Bragin, 1999, Hippocampal and entorhinal cortex high-frequency oscillations (100–500 Hz) in human epileptic brain and in kainic acid-treated rats with chronic seizures, Epilepsia, 40, 127, 10.1111/j.1528-1157.1999.tb02065.x Andrade-Valenca, 2011, Interictal scalp fast oscillations as a marker of the seizure onset zone, Neurology, 77, 524, 10.1212/WNL.0b013e318228bee2 Labate, 2015, White matter abnormalities differentiate severe from benign temporal lobe epilepsy, Epilepsia, 56, 1109, 10.1111/epi.13027 Noebels, 2015, Pathway-driven discovery of epilepsy genes, Nat Neurosci, 18, 344, 10.1038/nn.3933 Kauffman, 2008, GABABR1 (G1465A) gene variation and temporal lobe epilepsy controversy: new evidence, Seizure, 17, 567, 10.1016/j.seizure.2007.12.006 Xi, 2011, GABBR1 gene polymorphism(G1465A) is associated with temporal lobe epilepsy, Epilepsy Res, 96, 58, 10.1016/j.eplepsyres.2011.04.014 Gambardella, 2003, GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy, Neurology, 60, 560, 10.1212/01.WNL.0000046520.79877.D8 Wang, 2008, Association between the gamma-aminobutyric acid type B receptor 1 and 2 gene polymorphisms and mesial temporal lobe epilepsy in a Han Chinese population, Epilepsy Res, 81, 198, 10.1016/j.eplepsyres.2008.06.001 Pernhorst, 2011, Promoter variants determine gamma-aminobutyric acid homeostasis-related gene transcription in human epileptic hippocampi, J Neuropathol Exp Neurol, 70, 1080, 10.1097/NEN.0b013e318238b9af Haerian, 2015, Contribution of GABRG2 polymorphisms to risk of epilepsy and febrile seizure: a multicenter cohort study and meta-analysis, Mol Neurobiol Balan, 2013, GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures, Pharmacogenet Genomics, 23, 605, 10.1097/FPC.0000000000000000 Darrah, 2013, Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI, Epilepsy Res, 103, 180, 10.1016/j.eplepsyres.2012.07.006 Stefulj, 2010, Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy, Neurosci Lett, 478, 29, 10.1016/j.neulet.2010.04.060 Manna, 2007, Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy, Neurosci Lett, 421, 52, 10.1016/j.neulet.2007.05.022 Li, 2012, Association study of functional polymorphisms in serotonin transporter gene with temporal lobe epilepsy in Han Chinese population, Eur J Neurol, 19, 351, 10.1111/j.1468-1331.2011.03521.x 2014, Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies, Lancet Neurol, 13, 893, 10.1016/S1474-4422(14)70171-1 Stogmann, 2002, A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy, Ann Neurol, 51, 260, 10.1002/ana.10108 Scher, 2011, MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohort, J Neurotrauma, 28, 1739, 10.1089/neu.2011.1982 Lv, 2011, ASIC1a polymorphism is associated with temporal lobe epilepsy, Epilepsy Res, 96, 74, 10.1016/j.eplepsyres.2011.05.002 Zhang, 2014, Evidence for involvement of the CD40/CD40L system in post-stroke epilepsy, Neurosci Lett, 567, 6, 10.1016/j.neulet.2014.03.003 Kanemoto, 2003, Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion, Epilepsia, 44, 796, 10.1046/j.1528-1157.2003.43302.x Kanemoto, 2000, Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy, Ann Neurol, 47, 571, 10.1002/1531-8249(200005)47:5<571::AID-ANA3>3.0.CO;2-A Salzmann, 2008, Candidate genes for temporal lobe epilepsy: a replication study, Neurol Sci, 29, 397, 10.1007/s10072-008-1060-9 Yang, 2014, The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels, PLoS One, 9, e109634, 10.1371/journal.pone.0109634 Liu, 2015, Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy, Gene, 571, 231, 10.1016/j.gene.2015.06.055 Labate, 2007, Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women, Neurosci Lett, 421, 1, 10.1016/j.neulet.2006.10.020 Nwaobi, 2016, The role of glial-specific Kir4.1 in normal and pathological states of the CNS, Acta Neuropathol, 10.1007/s00401-016-1553-1 Buono, 2004, Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility, Epilepsy Res, 58, 175, 10.1016/j.eplepsyres.2004.02.003 Heuser, 2010, Variants of the genes encoding AQP4 and Kir4.1 are associated with subgroups of patients with temporal lobe epilepsy, Epilepsy Res, 88, 55, 10.1016/j.eplepsyres.2009.09.023 Lv, 2011, A polymorphism in CALHM1 is associated with temporal lobe epilepsy, Epilepsy Behav, 20, 681, 10.1016/j.yebeh.2011.02.007 Zhu, 2016, Contribution of NRG1 gene polymorphisms in temporal lobe epilepsy, J Child Neurol, 31, 271, 10.1177/0883073815589757 Shen, 2016, Role of BDNF Val66Met functional polymorphism in temporal lobe epilepsy, Int J Neurosci, 126, 436, 10.3109/00207454.2015.1026967 Jamali, 2010, Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures, PLoS One, 5, e12740, 10.1371/journal.pone.0012740 Leu, 2016, Progress from genome-wide association studies and copy number variant studies in epilepsy, Curr Opin Neurol, 29, 158, 10.1097/WCO.0000000000000296 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Jimenez-Mateos, 2013, Epilepsy and microRNA, Neuroscience, 238, 218, 10.1016/j.neuroscience.2013.02.027 Aronica, 2010, Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy, Eur J Neurosci, 31, 1100, 10.1111/j.1460-9568.2010.07122.x Kaalund, 2014, Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance, Epilepsia, 55, 2017, 10.1111/epi.12839 Miller-Delaney, 2015, Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy, Brain, 138, 616, 10.1093/brain/awu373 Zucchini, 2014, Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology, PLoS One, 9, e105521, 10.1371/journal.pone.0105521 Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat Biotechnol, 29, 341, 10.1038/nbt.1807 Haqqani, 2013, Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells, Fluids Barriers CNS, 10, 4, 10.1186/2045-8118-10-4 Jin, 2013, Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases, Cell Mol Neurobiol, 33, 601, 10.1007/s10571-013-9940-9 Gorter, 2014, Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy, Neurobiol Dis, 62, 508, 10.1016/j.nbd.2013.10.026 Roncon, 2015, MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy—comparison with human epileptic samples, Sci Rep, 5, 14143, 10.1038/srep14143 McDonald, 2011, Analysis of circulating microRNA: preanalytical and analytical challenges, Clin Chem, 57, 833, 10.1373/clinchem.2010.157198 Immonen, 2013, MRI biomarkers for post-traumatic epileptogenesis, J Neurotrauma, 30, 1305, 10.1089/neu.2012.2815 Lewis, 2014, Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study, Ann Neurol, 75, 178, 10.1002/ana.24081 Lehto, 2012, Detection of calcifications in vivo and ex vivo after brain injury in rat using SWIFT, Neuroimage, 61, 761, 10.1016/j.neuroimage.2012.03.002 Fisher, 2005, Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE), Epilepsia, 46, 470, 10.1111/j.0013-9580.2005.66104.x Fisher, 2014, ILAE official report: a practical clinical definition of epilepsy, Epilepsia, 55, 475, 10.1111/epi.12550 Jacobs, 2012, High-frequency oscillations (HFOs) in clinical epilepsy, Prog Neurobiol, 98, 302, 10.1016/j.pneurobio.2012.03.001 Bragin, 2004, High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis, Epilepsia, 45, 1017, 10.1111/j.0013-9580.2004.17004.x Haegelen, 2013, High-frequency oscillations, extent of surgical resection, and surgical outcome in drug-resistant focal epilepsy, Epilepsia, 54, 848, 10.1111/epi.12075 Weiss, 2013, Ictal high frequency oscillations distinguish two types of seizure territories in humans, Brain, 136, 3796, 10.1093/brain/awt276 Akiyama, 2011, Focal resection of fast ripples on extraoperative intracranial EEG improves seizure outcome in pediatric epilepsy, Epilepsia, 52, 1802, 10.1111/j.1528-1167.2011.03199.x Kerber, 2014, Differentiation of specific ripple patterns helps to identify epileptogenic areas for surgical procedures, Clin Neurophysiol, 125, 1339, 10.1016/j.clinph.2013.11.030 Salami, 2014, Dynamics of interictal spikes and highfrequency oscillations during epileptogenesis in temporal lobe epilepsy, Neurobiol Dis, 67, 97, 10.1016/j.nbd.2014.03.012 Levesque, 2012, Two seizure-onset types reveal specific patterns of high-frequency oscillations in a model of temporal lobe epilepsy, J Neurosci, 32, 13264, 10.1523/JNEUROSCI.5086-11.2012 Jacobs, 2016, The identification of distinct high-frequency oscillations during spikes delineates the seizure onset zone better than high-frequency spectral power changes, Clin Neurophysiol, 127, 129, 10.1016/j.clinph.2015.04.053 Xiang, 2015, Quantification of interictal neuromagnetic activity in absence epilepsy with accumulated source imaging, Brain Topogr, 28, 904, 10.1007/s10548-014-0411-5 Tenney, 2014, Low- and high-frequency oscillations reveal distinct absence seizure networks, Ann Neurol, 76, 558, 10.1002/ana.24231 Xiang, 2014, Accumulated source imaging of brain activity with both low and high-frequency neuromagnetic signals, Front Neuroinform, 8, 57, 10.3389/fninf.2014.00057 Amiri, 2016, High frequency oscillations and spikes: separating real HFOs from false oscillations, Clin Neurophysiol, 127, 187, 10.1016/j.clinph.2015.04.290 Dümpelmann, 2015, Temporal and spatial characteristics of high frequency oscillations as a new biomarker in epilepsy, Epilepsia, 56, 197, 10.1111/epi.12844 Kharatishvili, 2010, Posttraumatic epilepsy, Curr Opin Neurol, 23, 183, 10.1097/WCO.0b013e32833749e4 Rattka, 2011, Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats, Neuropharmacology, 60, 505, 10.1016/j.neuropharm.2010.11.005 Bolkvadze, 2012, Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse, J Neurotrauma, 29, 789, 10.1089/neu.2011.1954 Rattka, 2012, Do proconvulsants modify or halt epileptogenesis? Pentylenetetrazole is ineffective in two rat models of temporal lobe epilepsy, Eur J Neurosci, 36, 2505, 10.1111/j.1460-9568.2012.08143.x Brima, 2013, Increased susceptibility to pentetrazol-induced seizures in developing rats after cortical photothrombotic ischemic stroke at P7, Brain Res, 1507, 146, 10.1016/j.brainres.2013.02.037 Mishra, 2014, Decreased resting functional connectivity after traumatic brain injury in the rat, PLoS One, 9, e95280, 10.1371/journal.pone.0095280 Brandt, 2015, Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers, Neurobiol Dis, 75, 78, 10.1016/j.nbd.2014.12.015 Bröer, 2015, Novel combinations of phenotypic biomarkers predict development of epilepsy in the lithium-pilocarpine model of temporal lobe epilepsy in rats, Epilepsy Behav, 53, 98, 10.1016/j.yebeh.2015.09.028 Filibian, 2012, In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity, Epilepsia, 53, 1907, 10.1111/j.1528-1167.2012.03685.x Wieser, 1979, Comparative value of spontaneous and chemically and electrically induced seizures in establishing the lateralization of temporal lobe seizures, Epilepsia, 20, 47, 10.1111/j.1528-1157.1979.tb04775.x Barba, 2012, Diagnostic yield and predictive value of provoked ictal SPECT in drug-resistant epilepsies, J Neurol, 259, 1613, 10.1007/s00415-011-6387-0 Barba, 2009, Provoked ictal SPECT in temporal and extratemporal drug-resistant epileptic patients: comparison of statistical parametric mapping and qualitative analysis, Epilepsy Res, 84, 6, 10.1016/j.eplepsyres.2008.11.017 So, 1989, Depth electrode investigations in patients with bitemporal epileptiform abnormalities, Ann Neurol, 25, 423, 10.1002/ana.410250502 Guo, 2009, In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: an 18F-fluorodeoxyglucose-small animal positron emission tomography study, Neuroscience, 162, 972, 10.1016/j.neuroscience.2009.05.041 Shultz, 2013, Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome?, Epilepsia, 54, 1240, 10.1111/epi.12223 McGinnity, 2015, NMDA receptor binding in focal epilepsies, J Neurol Neurosurg Psychiatry, 86, 1150, 10.1136/jnnp-2014-309897 Syvanen, 2012, Altered GABAA receptor density and unaltered blood–brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET, J Nucl Med, 53, 1974, 10.2967/jnumed.112.104588 Filiou, 2014, ‘Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared, Neurogenetics, 15, 201, 10.1007/s10048-014-0409-x Vezzani, 2011, IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures, Brain Behav Immun, 25, 1281, 10.1016/j.bbi.2011.03.018 Vezzani, 2011, The role of inflammation in epilepsy, Nat Rev Neurol, 7, 31, 10.1038/nrneurol.2010.178 Vezzani, 2013, Epilepsy and brain inflammation, Exp Neurol, 244, 11, 10.1016/j.expneurol.2011.09.033 Ravizza, 2011, Inflammation and prevention of epileptogenesis, Neurosci Lett, 497, 223, 10.1016/j.neulet.2011.02.040 Vezzani, 2016, Infections, inflammation and epilepsy, Acta Neuropathol, 131, 211, 10.1007/s00401-015-1481-5 Tomkins, 2011, Blood–brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy, Cardiovasc Psychiatry Neurol, 2011, 765923, 10.1155/2011/765923 Pulli, 2014, Imaging neuroinflammation—from bench to bedside, J Clin Cell Immunol, 5, 226 Amhaoul, 2014, Imaging brain inflammation in epilepsy, Neuroscience, 279, 238, 10.1016/j.neuroscience.2014.08.044 Barry, 2015, T2 relaxation time post febrile status epilepticus predicts cognitive outcome, Exp Neurol, 269, 242, 10.1016/j.expneurol.2015.04.015 Gershen, 2015, Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein, JAMA Neurol, 72, 882, 10.1001/jamaneurol.2015.0941 Shinnar, 2008, Phenomenology of prolonged febrile seizures: results of the FEBSTAT study, Neurology, 71, 170, 10.1212/01.wnl.0000310774.01185.97 Cacheaux, 2009, Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis, J Neurosci, 29, 8927, 10.1523/JNEUROSCI.0430-09.2009 Weissberg, 2015, Albumin induces excitatory synaptogenesis through astrocytic TGF-beta/ALK5 signaling in a model of acquired epilepsy following blood–brain barrier dysfunction, Neurobiol Dis, 78, 115, 10.1016/j.nbd.2015.02.029 Shlosberg, 2010, Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury, Nat Rev Neurol, 6, 393, 10.1038/nrneurol.2010.74 Pitkänen, 2016, Development of epilepsy after ischaemic stroke, Lancet Neurol, 15, 185, 10.1016/S1474-4422(15)00248-3 Rodriguez-Baeza, 2003, Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study, Anat Rec A Discov Mol Cell Evol Biol, 273, 583, 10.1002/ar.a.10069 Rigau, 2007, Angiogenesis is associated with blood–brain barrier permeability in temporal lobe epilepsy, Brain, 130, 1942, 10.1093/brain/awm118 van Vliet, 2007, Blood–brain barrier leakage may lead to progression of temporal lobe epilepsy, Brain, 130, 521, 10.1093/brain/awl318 Raabe, 2012, Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions, Epilepsia, 53, 539, 10.1111/j.1528-1167.2012.03405.x Wei, 2009, The long-term microvascular and behavioural consequences of experimental traumatic brain injury after hypothermic intervention, J Neurotrauma, 26, 527, 10.1089/neu.2008.0797 Ding, 2006, Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat, Brain Res, 1114, 195, 10.1016/j.brainres.2006.07.116 Veksler, 2014, Blood–brain barrier imaging in human neuropathologies, Arch Med Res, 45, 646, 10.1016/j.arcmed.2014.11.016 Tomkins, 2008, Blood–brain barrier disruption in post-traumatic epilepsy, J Neurol Neurosurg Psychiatry, 79, 774, 10.1136/jnnp.2007.126425 Pavlovsky, 2005, Persistent BBB disruption may underlie alpha interferon-induced seizures, J Neurol, 252, 42, 10.1007/s00415-005-0596-3 Pitkänen, 2005, Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat, Epilepsy Res, 63, 27, 10.1016/j.eplepsyres.2004.10.003 Shrot, 2014, Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment, Toxicology, 323, 19, 10.1016/j.tox.2014.05.010 Ravizza, 2008, Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy, Neurobiol Dis, 29, 142, 10.1016/j.nbd.2007.08.012 Dyhrfjeld-Johnsen, 2010, Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis, J Clin Neurophysiol, 27, 418, 10.1097/WNP.0b013e3181fe0709 Erdmann, 2015, All aboard: will molecular tumor boards help cancer patients?, Nat Med, 21, 655, 10.1038/nm0715-655 McDermott, 2013, Challenges in biomarker discovery: combining expert insights with statistical analysis of complex omics data, Expert Opin Med Diagn, 7, 37, 10.1517/17530059.2012.718329 Atluri, 2013, Complex biomarker discovery in neuroimaging data: finding a needle in a haystack, Neuroimage Clin, 3, 123, 10.1016/j.nicl.2013.07.004 Humpel, 2011, Identifying and validating biomarkers for Alzheimer's disease, Trends Biotechnol, 29, 26, 10.1016/j.tibtech.2010.09.007 Rosen, 2013, Fluid biomarkers in Alzheimer's disease—current concepts, Mol Neurodegener, 8, 20, 10.1186/1750-1326-8-20 Di Battista, 2015, Blood biomarkers in moderate-to-severe traumatic brain injury: potential utility of a multi-marker approach in characterizing outcome, Front Neurol, 6, 110, 10.3389/fneur.2015.00110 Milward, 2014, Beyond statistics: a new combinatorial approach to identifying biomarker panels for the early detection and diagnosis of Alzheimer's disease, J Alzheimers Dis, 39, 211, 10.3233/JAD-131424 Gao, 2015, Multistage adaptive biomarker-directed targeted design for randomized clinical trials, Contemp Clin Trials, 42, 119, 10.1016/j.cct.2015.03.001